Johnson & Johnson (JNJ.US) has agreed to pay more than $8.2 billion to settle lawsuits over its baby powder's cancer risk.
Friday, Sep 20, 2024 9:40 am ET
1min read Johnson & Johnson (JNJ.US) has raised the amount it is willing to pay to settle thousands of lawsuits alleging its baby powder caused cancer to over $8.2 billion from its previous offer of $6.5 billion, according to people familiar with the matter. The decision to increase the settlement amount will bring the total amount Johnson & Johnson has agreed to pay or has already paid to resolve lawsuits related to its baby powder to over $13.4 billion. The new terms also allow claimants to receive higher compensation and about $650 million in legal fees, the people said. Negotiations are ongoing.
Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.